Mainstream

Medtronic outlines acceleration to 5% organic revenue growth and raises EPS guidance to $5.60-$5.66, driven by CAS and innovation investments

Medtronic outlines acceleration to 5% organic revenue growth and raises EPS guidance to $5.60-$5.66, driven by CAS and innovation investments

Post ContentmdtRead More

You might also be interested in reading CoinDesk 20 Performance Update: RENDER Falls 10.7% as Nearly All Assets Trade Lower.

August 19, 2025
In Mainstream